BAKER CHARLES A 4
4 · REGENERON PHARMACEUTICALS INC · Filed Jan 3, 2018
Insider Transaction Report
Form 4
BAKER CHARLES A
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2018-01-02+7,439→ 7,439 totalExercise: $380.95Exp: 2028-01-02→ Common Stock (7,439 underlying)
Footnotes (1)
- [F1]The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.